Rabavert Market Report 2026

Rabavert Market Overview

• The Rabavert market growth in the historic period has been driven by rising incidence of animal bite exposures, expansion of public health immunization campaigns • Market expansion is supported by increasing investments in vaccine manufacturing capacity, growing demand for travel-related immunization • Growth Driver: Rising Rabies Cases Driving Growth In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Rabavert Market?

Rabavert is a vaccine specifically designed to prevent rabies, a life-threatening viral infection that targets the central nervous system and is almost always fatal once symptoms appear. This purified, inactivated rabies virus vaccine offers reliable protection for individuals at risk of rabies exposure, including those bitten or scratched by potentially infected animals, as well as individuals working in high-risk environments such as veterinary clinics, wildlife conservation, or laboratories handling rabies virus samples. The main indications of rabavert are pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). Pre-Exposure Prophylaxis (PrEP) refers to preventive treatment administered to individuals at high risk of exposure to a particular disease, such as rabies or HIV, to reduce the likelihood of infection before potential contact with the pathogen. It is used by hospitals, clinics, and public health organizations and is distributed by various channels such as direct sales, wholesalers or distributors, and online pharmacies.

What Is The Rabavert Market Growth Forecast?

The growth in the forecast period can be attributed to increasing investments in vaccine manufacturing capacity, growing demand for travel-related immunization, expansion of public-private vaccination initiatives, rising focus on zoonotic disease prevention, increasing adoption of digital immunization records. Major trends in the forecast period include increasing adoption of preventive vaccination programs, rising demand for post-exposure prophylaxis vaccines, growing focus on occupational immunization coverage, expansion of cold-chain vaccine distribution, enhanced vaccine safety monitoring.

Global Rabavert Market Segmentation

1) By Indication: Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP) 2) By Distribution Channel: Direct Sales, Wholesalers Or Distributors, Online Pharmacies 3) By End User: Hospitals, Clinics, Public Health Organizations

What Are The Drivers Of The Rabavert Market?

The increasing number of cases of rabies is expected to propel the growth of the rabavert market going forward. Rabies is a deadly viral infection that targets the central nervous system, causing inflammation in the brain and spinal cord. The increasing number of rabies cases is attributed to factors such as inadequate vaccination programs for animals, poor public awareness regarding preventive measures, the growing population of stray animals, and limited access to healthcare services, particularly in rural and underdeveloped areas. RabAvert is used for post-exposure prophylaxis and pre-exposure prevention of rabies by stimulating the immune system to produce antibodies against the rabies virus. For instance, in April 2024, according to the report published by the South Dakota Department of Health, a US-based government agency, South Dakota reported 20 rabies cases in animals in 2023, a 122% increase compared to the 9 cases recorded in 2022. Therefore, the increasing number of cases of rabies is driving the growth of the rabavert industry. The rising government initiatives are expected to accelerate the growth of the rabavert market going forward. Government initiatives are organized actions, policies, or programs implemented by government entities to address specific issues, improve public welfare, or stimulate social or economic development. Rising government initiatives are driven by several key factors, including the need to address pressing public health issues, stimulate economic recovery, and meet sustainability goals. Rabavert contributes to government initiatives focused on rabies prevention by providing a reliable vaccine, supporting public health campaigns, improving access to post-exposure prophylaxis, and aiding global efforts toward rabies control and eradication. For instance, in September 2023, according to the report published by the Animal and Plant Health Inspection Service (APHIS), a US-based government agency, each year, four million Americans are bitten or scratched by animals, with 60,000 receiving post-exposure prophylaxis (PEP) to prevent rabies, contributing to the growing annual cost of over $600 million for rabies prevention and control in the US. Therefore, the rising government initiatives are driving the growth of the rabavert industry. Increasing pet ownership is expected to propel the growth of the rabavert market going forward. Pet ownership refers to the practice of keeping animals, such as dogs, cats, or other species, as companions, providing them with care, shelter, and affection, often enhancing human well-being and emotional health. Pet ownership is growing due to increasing companionship needs, improving emotional well-being, and changing lifestyles that prioritize pets as family members. The rise in pet ownership has led to increased use of RabAvert, as it delivers crucial rabies protection for pets, safeguarding their health and minimizing the risk of rabies transmission to humans. For instance, in 2025, according to a report of the People's Dispensary for Sick Animals, a UK-based veterinary charity, there were an estimated 11.1 million pet dogs in the UK (30% of adults have one), 10.5 million pet cats (24% of adults), and about 700,000 pet rabbits (2% of adults). Therefore, the increasing pet ownership will drive the growth of the rabavert industry.

Key Players In The Global Rabavert Market

Major companies operating in the rabavert market are Bavarian Nordic A/S

Regional Insights

North America was the largest region in the rabavert market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Rabavert Market?

The rabavert market consists of sales of injections, powders, and lyophilized products for suspension. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Rabavert Market Report 2026?

The rabavert market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rabavert industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.